These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2991689)

  • 1. The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease.
    Jolkkonen JT; Soininen HS; Riekkinen PJ
    Life Sci; 1985 Aug; 37(7):585-90. PubMed ID: 2991689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.
    Soininen H; Pitkänen A; Halonen T; Riekkinen PJ
    Acta Neurol Scand; 1984 Jul; 70(1):29-34. PubMed ID: 6147948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
    Soininen H; Koskinen T; Helkala EL; Pigache R; Riekkinen PJ
    Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease?
    Partanen JV; Soininen H; Riekkinen PJ
    Electroencephalogr Clin Neurophysiol; 1986 Jun; 63(6):547-51. PubMed ID: 2422004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
    J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease.
    Heuser I; Heuser-Link M; Gotthardt U; Grasser A; Holsboer F
    J Clin Psychopharmacol; 1993 Jun; 13(3):171-4. PubMed ID: 8394847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First clinical impressions with an ACTH analog (HOE 427) in the treatment of Alzheimer's disease.
    Siegfried KR
    Ann N Y Acad Sci; 1991; 640():280-3. PubMed ID: 1663715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
    O'Connor DT; Cervenka JH; Stone RA; Levine GL; Parmer RJ; Franco-Bourland RE; Madrazo I; Langlais PJ; Robertson D; Biaggioni I
    Clin Sci (Lond); 1994 Feb; 86(2):149-58. PubMed ID: 8143425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ACTH 4-9 analog (Org 2766) and cognitive performance: high-dose efficacy and safety in dementia of the Alzheimer's type.
    Miller TP; Fong K; Tinklenberg JR
    Biol Psychiatry; 1993 Feb; 33(4):307-9. PubMed ID: 8386005
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of adrenocorticotropic hormone (ACTH4-10) on information network of the cardiovascular systems].
    Dmitrieva NV; Lonskaia LF; Bakaneva VF
    Vestn Ross Akad Med Nauk; 2010; (3):21-4. PubMed ID: 20420211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
    Öhrfelt A; Brinkmalm A; Dumurgier J; Brinkmalm G; Hansson O; Zetterberg H; Bouaziz-Amar E; Hugon J; Paquet C; Blennow K
    Alzheimers Res Ther; 2016 Oct; 8(1):41. PubMed ID: 27716408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of ACTH4-9 analogue on the Ca2+ level of mouse hippocampal synaptosomes].
    Luo L; Zhang WN; Zheng YL; Wu FM
    Sheng Li Xue Bao; 1998 Aug; 50(4):449-52. PubMed ID: 11324556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
    Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.
    Simons M; Schwärzler F; Lütjohann D; von Bergmann K; Beyreuther K; Dichgans J; Wormstall H; Hartmann T; Schulz JB
    Ann Neurol; 2002 Sep; 52(3):346-50. PubMed ID: 12205648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the efficacy of ACTH4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis.
    Butter HJ; Lapierre Y; Firestone P; Blank A
    J Clin Psychopharmacol; 1983 Aug; 3(4):226-30. PubMed ID: 6309918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)].
    Schneider E; Jacobi P; van Riezen H; Voerman JW; Fischer PA
    Pharmacopsychiatria; 1981 Sep; 14(5):155-9. PubMed ID: 6270708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
    Risby ED; Hsiao JK; Sunderland T; Agren H; Rudorfer MV; Potter WZ
    Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the ACTH4-9 analog Org2766 on brain plasticity: modulation of excitatory neurotransmission?
    Spruijt BM
    Psychoneuroendocrinology; 1992 Aug; 17(4):315-25. PubMed ID: 1332099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cerebrospinal fluid cAMP levels in Alzheimer's disease.
    Martínez M; Fernández E; Frank A; Guaza C; de la Fuente M; Hernanz A
    Brain Res; 1999 Nov; 846(2):265-7. PubMed ID: 10556645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.